Nathan Bahr

,

Credentials

MD, FIDSA

Bio

Dr. Bahr received his undergraduate degree from Loras College in Dubuque Iowa. He attended medical school at Loyola University Chicago Stritch School of medicine where he also completed a MA in bioethics and health policy. Dr. Bahr completed a MS in clinical research at the University of Kansas Medical Center.

Dr. Bahr trained in internal medicine and infectious diseases at the University of Minnesota where he began to develop his career path at the intersection of infectious diseases research and global health. As
part of Dr. Bahr's training he received a Fogarty Fellowship from the NIH and spent that year in Uganda working to improve diagnosis of TB meningitis as part of team at the Infectious Diseases Institute of Makerere University. He subsequently completed his infectious diseases training at the University of Kansas Medical Center and was on faculty there until coming back to the University of Minnesota in 2024.

Dr Bahr continues to work closely with collaborators in Uganda and around the world with a heavy focus on improving outcomes in persons with TB meningitis, cryptococcal meningitis and histoplasmosis as well as blastomycosis. Dr. Bahr is passionate about leveraging his expertise to work on improving outcomes in conditions that disproportionately affect disadvantaged populations.

Awards and Recognition Received
Outstanding Junior Investigator, Department of Internal Medicine, KUMC, 2022; Fellow IDSA 2022; Jeevan Paul Humanitarian Award – University of Minnesota Internal Medicine Residency Program 2012

Professional Memberships and Affiliations
American College of Physicians; Infectious Diseases Society of America; Mycoses Study Group Education and Research Consortium; TB Meningitis International Research Consortium

Research Summary

Tuberculosis meningitis; histoplasmosis; blastomycosis; cryptococcal meningitis; pharmaceutical pricing

Teaching Summary

CNS infections; endemic fungal infections; tuberculosis; general approach to infectious diseases

Clinical Summary

Endemic mycoses; HIV; CNS infections; general infectious diseases